SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-115375
Filing Date
2023-11-07
Accepted
2023-11-07 18:33:24
Documents
1
Period of Report
2023-11-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2330145-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2330145-2_4seq1.xml 4 4010
  Complete submission text file 0001104659-23-115375.txt   5423
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Issuer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address
MCCANN JOE A. (Reporting) CIK: 0001868644 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39373 | Film No.: 231385454